drugset / Trial / NCT00753558

Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae

NCT00753558

Summary

There is an urgent need to control our current national outbreak of carbapenem-resistant Klebsiella pneumoniae (CRKP). The purpose of this study is to eradicate CRKP gastrointestinal carriage using selective digestive decontamination (SDD); with buccal and oral gentamicin and polymyxin E administration. This will reduce infections and hopefully mortality caused by CRKP.

Timeline

Start
2008-11
Primary completion
2010-06
Completion
2010-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Colistin Other / unclassified Oral
Comparator Gentamicin Small molecule Oral

Indications

No indication recorded.